Skip to main content
Fig. 1 | Cancer Nanotechnology

Fig. 1

From: Synergistic co-administration of docetaxel and curcumin to chemoresistant cancer cells using PEGylated and RIPL peptide-conjugated nanostructured lipid carriers

Fig. 1

Characteristics of different empty and docetaxel (DTX)- or curcumin (CUR)-loaded nanostructured lipid carriers (NLC)s. A Transmission electron microscopy (TEM) images of empty and DTX- or CUR-loaded NLCs. Scale bar represents 200 nm. B Changes in particle size, polydispersity index (PDI), zeta potential (ZP), and drug loading (DL) capacity on storage at 4 °C for 4 weeks. Data represent the mean ± SD (n = 3)

Back to article page